Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries

BACKGROUND: The availability of methotrexate and the introduction of multiple biological agents have revolutionized the treatment of juvenile idiopathic arthritis (JIA). Several international and national drug registries have been implemented to accurately monitor the long-term safety/efficacy of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Swart, Joost, Giancane, Gabriella, Horneff, Gerd, Magnusson, Bo, Hofer, Michael, Alexeeva, Еkaterina, Panaviene, Violeta, Bader-Meunier, Brigitte, Anton, Jordi, Nielsen, Susan, De Benedetti, Fabrizio, Kamphuis, Sylvia, Staņēviča, Valda, Tracahana, Maria, Ailioaie, Laura Marinela, Tsitsami, Elena, Klein, Ariane, Minden, Kirsten, Foeldvari, Ivan, Haas, Johannes Peter, Klotsche, Jens, Horne, Anna Carin, Consolaro, Alessandro, Bovis, Francesca, Bagnasco, Francesca, Pistorio, Angela, Martini, Alberto, Wulffraat, Nico, Ruperto, Nicolino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307151/
https://www.ncbi.nlm.nih.gov/pubmed/30587248
http://dx.doi.org/10.1186/s13075-018-1780-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307151/
https://www.ncbi.nlm.nih.gov/pubmed/30587248
http://dx.doi.org/10.1186/s13075-018-1780-z

Ejemplares similares